BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12899067)

  • 21. [Changing aspects of corticosteroid therapy in rheumatic diseases (proceedings)].
    Jesserer H
    Acta Med Austriaca Suppl; 1976; 3():202. PubMed ID: 1072572
    [No Abstract]   [Full Text] [Related]  

  • 22. Altered neuroendocrine immune (NEI) networks in rheumatology.
    Cutolo M; Bijlsma JW; Lahita RG; Masi AT; Straub RH; Bradlow HL
    Ann N Y Acad Sci; 2002 Jun; 966():xiii-xviii. PubMed ID: 12114252
    [No Abstract]   [Full Text] [Related]  

  • 23. Steroids in rheumatic disease: a podiatric perspective.
    Roth RD
    Clin Podiatr Med Surg; 1988 Jan; 5(1):135-54. PubMed ID: 2962716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent advances in the therapy of rheumatic diseases with corticosteroids. Personal experience].
    Clemmesen S
    Rev Clin Esp; 1970 Jun; 117(6):587-600. PubMed ID: 5518943
    [No Abstract]   [Full Text] [Related]  

  • 25. Nutrition and pediatric rheumatic diseases. Hypothesis: cytokines modulate nutritional abnormalities in rheumatic diseases.
    Ostrov BE
    J Rheumatol Suppl; 1992 Apr; 33():49-53. PubMed ID: 1593602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited.
    Buttgereit F; Wehling M; Burmester GR
    Arthritis Rheum; 1998 May; 41(5):761-7. PubMed ID: 9588727
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of glucocorticoids in therapy of rheumatic disease. 1: Value--precautions--choice of drug preparation].
    Kaiser H
    Fortschr Med; 1998 Nov; 116(32):44-5. PubMed ID: 9880952
    [No Abstract]   [Full Text] [Related]  

  • 28. [TNF-alpha antagonists in therapy of rheumatoid arthritis].
    Gross WL; Gause A
    Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691
    [No Abstract]   [Full Text] [Related]  

  • 29. Glucocorticoids and rheumatoid arthritis: back to the future?
    Moreland LW; O'Dell JR
    Arthritis Rheum; 2002 Oct; 46(10):2553-63. PubMed ID: 12384910
    [No Abstract]   [Full Text] [Related]  

  • 30. Inflamed joints and stiff arteries: is rheumatoid arthritis a cardiovascular risk factor?
    Quyyumi AA
    Circulation; 2006 Sep; 114(11):1137-9. PubMed ID: 16966595
    [No Abstract]   [Full Text] [Related]  

  • 31. Exogenous and endogenous glucocorticoids in rheumatic diseases.
    Buttgereit F; Burmester GR; Straub RH; Seibel MJ; Zhou H
    Arthritis Rheum; 2011 Jan; 63(1):1-9. PubMed ID: 20936628
    [No Abstract]   [Full Text] [Related]  

  • 32. Rheumatoid arthritis: neuroendocrine immune integrated physiopathogenetic perspectives and therapy.
    Masi AT; Aldag JC; Jacobs JW
    Rheum Dis Clin North Am; 2005 Feb; 31(1):131-60, x. PubMed ID: 15639060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of combined treatment of latent rheumatism and rheumatoid arthritis on the serotonin-binding capacity of thrombocytes].
    Matulis AA; Pliushkis AI
    Vopr Revm; 1974; (4):20-2. PubMed ID: 4548603
    [No Abstract]   [Full Text] [Related]  

  • 34. Tetracosactrin in the treatment of rheumatic diseases.
    Muirden KD
    Med J Aust; 1972 May; 1(21):1107-8. PubMed ID: 4339143
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hypothesis for the role of interferon in rheumatic diseases].
    Rosenbach T; Zor U; Yaron M
    Harefuah; 1984 Nov; 107(9):247-8. PubMed ID: 6084633
    [No Abstract]   [Full Text] [Related]  

  • 36. New glucocorticoids on the horizon: repress, don't activate!
    Song IH; Gold R; Straub RH; Burmester GR; Buttgereit F
    J Rheumatol; 2005 Jul; 32(7):1199-1207. PubMed ID: 16041872
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Bijlsma JWJ
    Ann Rheum Dis; 2024 Jan; 83(1):4-8. PubMed ID: 37739452
    [No Abstract]   [Full Text] [Related]  

  • 38. [The importance of enzymes in the treatment of rheumatic diseases].
    Kullich W
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 9():S316-8. PubMed ID: 19085661
    [No Abstract]   [Full Text] [Related]  

  • 39. Developments in glucocorticoid therapy.
    Bijlsma JW; Saag KG; Buttgereit F; da Silva JA
    Rheum Dis Clin North Am; 2005 Feb; 31(1):1-17, vii. PubMed ID: 15639052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential diagnosis to rheumatoid diseases. 1. Endocrine and metabolic aspects. 2. Treatment with corticoids.
    Bassøe HH
    Scand J Rheumatol Suppl; 1984; 53():46-53. PubMed ID: 6610929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.